Douglas C. Hankins - Concepedia

Author

Douglas C. Hankins

University of Washington

Also Known As

D C Hankins, D. C. Hankins, D. Hankins, DOUGLAS C. HANKINS, Douglas C. Hankins, Douglas Hankins, Douglas C. Hankins

Publications

871

Citations

H-Index

Concepts

All Affiliations

University of Washington VA Puget Sound Health Care System

About

Douglas C. Hankins is an author at University of Washington specializing in toxicology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	166
2	Biochemistry	2	2	155
3	Engineering	1	1	11
4	Health Sciences	1	1	46
5	Chemistry	1	1	11

Douglas C. Hankins

Publications

861

Citations

H-Index

Page 1

	Year	Citations
Human Kidney Methoxyflurane and Sevoflurane Metabolism Evan D. Kharasch, Douglas C. Hankins, Kenneth E. Thummel Anesthesiology	1995	231
Cytochrome P450 2E1 is the Principal Catalyst of Human Oxidative Halothane Metabolism in Vitro Douglas K. Spracklin, Douglas C. Hankins, Jeannine M. Fisher, Journal of Pharmacology and Experimental Therapeutics	1997	121
Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis Evan D. Kharasch, Douglas C. Hankins, Douglas S. Mautz, The Lancet HalogenationHepatologyBiochemistryMedicineLiver Physiology	1996	109
Role of Renal Cysteine Conjugate β-Lyase in the Mechanism of Compound A Nephrotoxicity in Rats Evan D. Kharasch, David Thorning, Kyle J. Garton, Anesthesiology	1997	103
Clinical Isoflurane Metabolism by Cytochrome P450 2E1 Evan D. Kharasch, Douglas C. Hankins, Kathy Cox Anesthesiology	1999	66
Role of the Renal Cysteine Conjugate β-Lyase Pathway in Inhaled Compound A Nephrotoxicity in Rats Evan D. Kharasch, Gary M. Hoffman, David Thorning, Anesthesiology	1998	53
Human halothane metabolism, lipid peroxidation, and cytochromes P 450 2A6 and P 450 3A4 Evan D. Kharasch, Douglas C. Hankins, K. Fenstamaker, European Journal of Clinical Pharmacology Human Halothane MetabolismP 450BiochemistryMedicineLipid Peroxidation	2000	46
Lack of Single-Dose Disulfiram Effects on Cytochrome P-450 2C9, 2C19, 2D6, and 3A4 Activities: Evidence for Specificity Toward P-450 2E1 Evan D. Kharasch, Douglas C. Hankins, Carole Jubert, Drug Metabolism and Disposition	1999	44
Single-Dose Methoxsalen Effects on Human Cytochrome P-450 2A6 Activity Evan D. Kharasch, Douglas C. Hankins, Julie K. Taraday Drug Metabolism and Disposition	2000	39
Single-dose disulfiram does not inhibit CYP2A6 activity* Evan D. Kharasch, Douglas C. Hankins, Pamela J. Baxter, Clinical Pharmacology & Therapeutics	1998	24

Page 1